-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Neutral on 10x Genomics, Raises Price Target to $30

Benzinga·04/20/2026 15:40:27
Listen to the news
B of A Securities analyst Derik De Bruin maintains 10x Genomics (NASDAQ:TXG) with a Neutral and raises the price target from $21 to $30.